BRIEF published on 10/24/2024 at 07:35, 1 year 9 months ago Rentschler Biopharma's Major Investment in German Headquarters Investment Rentschler Biopharma Biopharmaceuticals Facility Expansion Laupheim
PRESS RELEASE published on 10/24/2024 at 07:30, 1 year 9 months ago Rentschler Biopharma announces largest single investment at its headquarters in Germany Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
BRIEF published on 09/03/2024 at 13:05, 1 year 11 months ago Rentschler Biopharma présente une nouvelle boîte à outils de fabrication de vecteurs lentiviraux Thérapie Génique Produits Biopharmaceutiques Thérapies Avancées Vecteurs Lentiviraux Services De Fabrication
BRIEF published on 09/03/2024 at 13:05, 1 year 11 months ago Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE published on 09/03/2024 at 13:00, 1 year 11 months ago Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF published on 07/11/2024 at 14:05, 2 years 1 month ago Rentschler Biopharma Unveils New Production Line in Massachusetts Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
BRIEF published on 07/11/2024 at 14:05, 2 years 1 month ago Rentschler Biopharma dévoile une nouvelle ligne de production dans le Massachusetts Rentschler Biopharma Produits Biopharmaceutiques Massachusetts Ligne De Production
PRESS RELEASE published on 07/11/2024 at 14:00, 2 years 1 month ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 2 years 2 months ago Rentschler Biopharma nomme Patrick Meyer au poste de responsable mondial des ventes et de la gestion des alliances BD Rentschler Biopharma Produits Biopharmaceutiques Développement Des Affaires Patrick Meyer
BRIEF published on 05/28/2024 at 13:05, 2 years 2 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
Published on 08/12/2026 at 00:00, 7 hours 33 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 7 hours 53 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/11/2026 at 23:15, 8 hours 18 minutes ago Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador
Published on 08/11/2026 at 23:00, 8 hours 33 minutes ago Prospectiva Resources Ltd. Completes Qualifying Transaction
Published on 08/11/2026 at 22:55, 8 hours 38 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 08/12/2026 at 07:29, 4 minutes ago Bechtle accelerates growth in Q2 and upgrades its 2026 forecast
Published on 08/12/2026 at 07:10, 23 minutes ago Deutsche Konsum Real Estate AG publishes quarterly statement for the first nine months of the 2025/2026 financial year
Published on 08/12/2026 at 07:00, 33 minutes ago MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
Published on 08/12/2026 at 07:00, 33 minutes ago SCHOTT Pharma with strong third quarter and on track for planned growth
Published on 08/11/2026 at 17:45, 13 hours 48 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 13 hours 53 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 1 day 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 1 day 13 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
